(Protein Production Core) The Protein Production Core (PPC) serves as research support for the Oklahoma COBRE in Structural Biology (OCSB). It is a state-of the art facility for the expression and purification of protein for OCSB-supported researchers and the wider structural biology community. The PPC produces high quality proteins in a reliable and efficient manner on a fee-for-service basis and provides hands-on-training and expert advice in all aspects of protein expression and purification available in the facility. The PPC staff consists of a Director, Dr. Philip Bourne and a Graduate Student training position. The graduate student typically assists in the PPC for a semester. They are trained by the PPC director to use all of the equipment in the facility and assist in the day- to-day activities of the PPC. The PPC is guided by an advisory committee comprised of one junior and two senior faculty researchers. The PPC facility was established using OCSB Phase I funding. Milestones achieved during this period included: (i) renovation of laboratory space to create a stand-alone secure core facility, (ii) establishing the facility with modern instrumentation for protein expression and purification, and (iii) development of a user base. The user base has grown to twenty two research groups, including over 65 individual PPC users. Progress has been demonstrated by evidence of increased productivity of the user base i.e., publications and grant support. The PPC works closely with the investigators and the OCSB-supported Macromolecular Crystallography Laboratory (MCL) to produce homogeneous, highly purified protein for crystallization trials. The PPC is equipped with instrumentation and expertise frequently not found within individual research laboratories. Equipment housed in the PPC includes two refrigerated medium pressure chromatography systems and a large selection of columns for different purification techniques (affinity, hydrophobic, ion-exchange, and size exclusion). Other core equipment includes: an Emulsiflex-C3 homogenizer for lysis of yeast and bacterial cells; a high performance Avanti centrifuge, two freezers (-80 C and -20 C), and a BioRad ChemiDoc imager that detects UV, white and chemiluminescence. During the proposed Phase II of the OCSB, planned expansion of the PPC includes the addition of a low pressure chromatography system to ease the burden on the two medium pressure systems and expand the protein purification throughput of the facility. The addition of a small self-contained Dynamic Light Scattering instrument will allow for assessing the quality of samples prior to crystallization trials. This addition is ideal for a multi-user facility where a quick assessment of sample quality prior to crystallization experiments would be extremely useful. The increased protein production capacity and the expanded biophysical characterization will meet the existing demand and will help expand the user base. The larger user base will lead to more income from user fees and this will move the facility closer to self-sufficiency.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM103640-09
Application #
9934239
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
9
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Oklahoma Norman
Department
Type
DUNS #
848348348
City
Norman
State
OK
Country
United States
Zip Code
73019
Hebdon, Skyler D; Menon, Smita K; Richter-Addo, George B et al. (2018) Regulatory Targets of the Response Regulator RR_1586 from Clostridioides difficile Identified Using a Bacterial One-Hybrid Screen. J Bacteriol 200:
Cruz-Reyes, Jorge; Mooers, Blaine H M; Doharey, Pawan K et al. (2018) Dynamic RNA holo-editosomes with subcomplex variants: Insights into the control of trypanosome editing. Wiley Interdiscip Rev RNA 9:e1502
Booe, Jason M; Warner, Margaret L; Roehrkasse, Amanda M et al. (2018) Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists. Mol Pharmacol 93:355-367
Muthuramalingam, Meenakumari; White, John C; Murphy, Tamiko et al. (2018) The toxin from a ParDE toxin-antitoxin system found in Pseudomonas aeruginosa offers protection to cells challenged with anti-gyrase antibiotics. Mol Microbiol :
Roehrkasse, Amanda M; Booe, Jason M; Lee, Sang-Min et al. (2018) Structure-function analyses reveal a triple ?-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design. J Biol Chem 293:15840-15854
Terzyan, Simon S; Cook, Paul F; Heroux, Annie et al. (2017) Structure of 6-diazo-5-oxo-norleucine-bound human gamma-glutamyl transpeptidase 1, a novel mechanism of inactivation. Protein Sci 26:1196-1205
Guillen, Katrin P; Ruben, Eliza A; Virani, Needa et al. (2017) Annexin-directed ?-glucuronidase for the targeted treatment of solid tumors. Protein Eng Des Sel 30:85-94
Vazquez Reyes, Carolina; Tangprasertchai, Narin S; Yogesha, S D et al. (2017) Nucleic Acid-Dependent Conformational Changes in CRISPR-Cas9 Revealed by Site-Directed Spin Labeling. Cell Biochem Biophys 75:203-210
Van Orden, Mason J; Klein, Peter; Babu, Kesavan et al. (2017) Conserved DNA motifs in the type II-A CRISPR leader region. PeerJ 5:e3161
Murugan, Karthik; Babu, Kesavan; Sundaresan, Ramya et al. (2017) The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit. Mol Cell 68:15-25

Showing the most recent 10 out of 47 publications